Lists & Rankings
DraftKings: Why the stock could take off by September
DraftKings is one of the leading digital sports betting and gambling providers in North America. The...
Vishay Intertechnology: The Invisible Nerves of the Global Economy
As one of the world's leading manufacturers of passive components and discrete semiconductors, Vishay...
10x Genomics: Medicine in the 21st Century! 10x maps the entire transcriptome with Atera using 18,000 genes!
The markets are uncertain about their further direction. Many sectors are stagnant, and only the healthcare...
NWPX Infrastructure: Investments in Water Infrastructure Drive Stock to New All-Time High
NWPX Infrastructure manufactures and distributes pipe systems made of steel and concrete for water...
Pursuit Attractions and Hospitality: Competitive Advantage with "Once in a Lifetime" Nature Experiences
Pursuit Attractions and Hospitality has a strong competitive advantage with unique and nature-based...
NetApp: AI Boom & Q4 Beat Generate Momentum!
Trigger: A massive leap in profits in the fourth quarter and an extremely optimistic outlook lead...
the nLight Stock Soars: US Defense Deal Launches Price Rocket
Trigger: A strategic large order from the U.S. military worth up to $627 million significantly boosts...
Construction Partners: Record Orders Meet Strong Building Season
Construction Partners is one of the leading specialized road construction companies in the fast-growing...
The DoorDash Phenomenon! Delivery Giant with Record Figures, Subscription Records, and Global Advertising Plans!
At the beginning of the week, we want to take a look at the "Consumer Cyclical" sector. Despite inflation-driven...
Erasca: Here's how the Biotech Company Aims to Revolutionize Oncology
Erasca is a pure development company in precision oncology that currently has no products on the market...
Aehr Test Systems Benefits From Follow-up Orders for AI and Silicon Photonics
Aehr Test Systems develops and produces test and burn-in systems for the semiconductor industry, used...
BridgeBio Pharma: Attruby Becomes a Blockbuster – Main Competitor Fails in Phase 3 Trial
Attruby experienced almost 400% growth in the US as a treatment for the rare heart disease ATTR-CM....
Synaptics: Edge AI Boom and Massive Analyst Upgrade Ignite Stock Surge
The strategic realignment towards high-margin IoT solutions ends the industry-wide inventory correction...
Kirby: Rising Freight Rates and High Fleet Utilization Ignite Price Turbo
Kirby impresses with better-than-expected Q1 numbers and raised guidance thanks to rising freight...
Pivotal Point Tracking Meta Platforms (META): Social Media Giant Breaks Out Dynamically Thanks to Entry into AI Cloud Business
Meta Platforms operates the world's leading social networks with Facebook, Instagram, and WhatsApp, primarily...
Tracking the Pivotal Point of Ceva (CEVA): The Specialist in Semiconductor IP Benefits from Rising Licensing Demand
CEVA licenses signal processing IP, sensor hubs, and wireless connectivity solutions to semiconductor...
Applied Materials (AMAT) in our Pivotal Point Check: Unstoppable AI Boom Ensures Long-Term Guaranteed Orders – Analysts Raise Price Targets!
Long-term order outlook: CEO Gary Dickerson signals sustained high investments from chip manufacturers...
Zebra Technologies: From Barcode to Physical AI! Zebra Technologies is Well-Equipped for the AI era!
The technology sector is once again coming into greater focus for investors, moving up to fourth place....
Immix Biopharma: The Hunt for the Medical Bullseye
Immix Biopharma has a highly effective asset with its CAR-T cell therapy NXC-201, which has achieved...
Exelixis: Zanzalintinib as a Major Hope in Cancer Therapies Ahead of FDA Approval
Business Model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product,...
Exelixis: Zanzalintinib as a Great Hope in Cancer Therapies Before FDA Approval
Business model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product...
Septerna: Specialist in Oral GPCR Drugs Impresses with Strong Pipeline
SEP-479 targets the potential billion-dollar market for hypoparathyroidism and aims to replace current...
Illumina: Forecast increase and analyst praise drive trading volume
Strong numbers: Genomics specialist Illumina exceeds first-quarter earnings per share expectations...